Business Context and Reporting Period
This Form 8-K is a current report filed by InMed Pharmaceuticals Inc. on September 9, 2021. The company is incorporated in British Columbia and its common shares trade on The Nasdaq Stock Market LLC under the symbol INM. The filing serves as a Regulation FD disclosure regarding an upcoming corporate presentation.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report is limited to a disclosure of a scheduled event and does not contain financial statements or performance results.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces a scheduled presentation by the company's leadership.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Eric A. Adams, President and CEO, is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference.
- Event Details: The conference is being held virtually from September 13-15, 2021.
- Legal Status: The information provided, including the news release (Exhibit 99.1), is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the H.C. Wainwright 23rd Annual Global Investment Conference presentation.
- Review the full text of the news release (Exhibit 99.1) for any additional details on the presentation content.
- Check subsequent filings for any financial updates or guidance provided during the September 13-15, 2021 conference.